Developer docs
API playgroundTry for free, no card

Search company profiles

Integrated BioPharma

Full company profile

uuid003gc7r

Namestring
Integrated BioPharma
Legal namestring
Integrated BioPharma, Inc.
Company typeenum
Public
Founded yearint
1995
Descriptiontext

Integrated BioPharma, Inc. is a publicly traded (OTCQX: INBP), Delaware-incorporated holding company that manufactures, distributes, and sells vitamins, nutritional supplements, and herbal products for the nutraceutical industry. The company operates through five wholly owned subsidiaries: Manhattan Drug Company (contract manufacturing for distributors, multilevel marketers, and healthcare providers), AgroLabs (distribution to mass market, grocery, drug, and vitamin retailers), Chem International (raw materials distribution for DSM Nutritional Products), IHT Health Products (natural botanicals distribution under license), and MDC Warehousing and Distribution (warehousing and fulfillment services). Its core technology is US-based contract manufacturing of nutritional supplements with flexible customization capabilities, and its business model is B2B contract manufacturing and distribution with no disclosed direct-to-consumer or branded retail of its own.

The company is led by co-CEOs Christina Kay and Riva Kay Sheppard, who have served since the early 1990s, alongside CFO Dina L. Masi. Headquartered in Hillside, New Jersey with manufacturing operations in New Jersey and a sales office in Florida, the company operates exclusively within the United States. Its customer base consists of distributors, multilevel marketers, specialized healthcare providers, and mass market retailers, with revenue heavily concentrated in two large contract manufacturing customers that have represented approximately 83-90% of total revenue in recent periods. The company has 11-50 employees and a small market capitalization consistent with its micro-cap OTCQX listing.

Financially, the company is in a clear revenue contraction phase: nine-month revenue ended March 31, 2026 was $34.1M, down 15.2% year-over-year, with quarterly declines of 27.3% in Q1 FY2026 and 10.3% in Q2 FY2026. The company has shifted from operating profitability to an operating loss of $1.1M in Q1 FY2026 and a net loss of $0.8M, indicating margin pressure alongside the volume decline. No AI capabilities, recent acquisitions, or product launches are evident in the available data, and the company's strategic posture is defensive as it manages customer concentration risk and top-line erosion.

Short descriptiontext

Integrated BioPharma is a US-based contract manufacturer and distributor of vitamins, nutritional supplements, and herbal products, serving nutraceutical distributors, multilevel marketers, and retailers through five operating subsidiaries from its Hillside, NJ headquarters.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHillside, United States
HQ citystring
Hillside
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract manufacturing, nutritional supplements, vitamins distribution, herbal products, nutraceutical industry
Industry3 codes
PRIMARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYAFAIAKAJ
Food-Grade Chemicals & Processing Aids Trading/Wholesale
Agriculture & Food Production/Food Distribution & Wholesale/Food Ingredients & Commodities Trading/Wholesale
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Chemical and Allied Products Merchant Wholesalers4246
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutraceutical Manufacturing
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Manufacturing
TypeOne Time License
Description

The company manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers through its subsidiary Manhattan Drug Company, Inc. This is the primary revenue driver.

stocktitan.net
2Product Distribution
TypeTransaction Fee
Description

Distribution of nutritional products through major mass market, grocery, drug, and vitamin retailers via subsidiaries including AgroLabs, Chem International, and IHT Health Products.

ir.ibiopharma.com
3Raw Materials Distribution
TypeTransaction Fee
Description

Distribution of certain raw materials for DSM Nutritional Products LLC through Chem International, Inc.

ir.ibiopharma.com
4Warehousing and Fulfillment Services
TypeProfessional Services
Description

Warehousing and fulfillment services provided through MDC Warehousing and Distribution, Inc.

ir.ibiopharma.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Manhattan Drug Company
Description

Contract manufacturer of vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers.

ir.ibiopharma.com
+3 more records
Core offering1 text field

Integrated BioPharma manufactures vitamins, nutritional supplements, and herbal products primarily through contract manufacturing relationships, and distributes nutritional products and raw materials through its subsidiaries. It serves the nutraceutical industry by providing US-manufactured, customizable products to distributors, multilevel marketers, healthcare providers, and mass-market retailers, complemented by warehousing and fulfillment services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Integrated BioPharma is a manufacturing and sales company engaged primarily in the manufacturing, distributing, marketing, and sales of vitamins, nutritional supplements, and herbal products. The company operates through five distinct subsidiaries: Manhattan Drug Company (contract manufacturing of vitamins and nutritional supplements), AgroLabs (distribution to mass market, grocery, and drug retailers), Chem International (raw materials distribution), IHT Health Products (natural botanicals distribution), and MDC Warehousing and Distribution (warehousing and fulfillment services). The portfolio is structured as a platform of operating companies serving the nutraceutical industry.

Product and service3 records
1Contract Manufacturing of Vitamins and Nutritional Supplements
CategoryContract Manufacturing
Description

Contract manufacturing of vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers, operated through subsidiary Manhattan Drug Company, Inc.

2Nutritional Product Distribution
CategoryNutritional Distribution
Description

Distribution of healthful nutritional products for sale through major mass market, grocery, drug, and vitamin retailers, with customization for resale or direct-to-consumer, operated through subsidiary AgroLabs, Inc.

3Raw Materials Distribution
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Chem International, Inc. serves as a distributor of certain raw materials for DSM Nutritional Products LLC, a major nutritional ingredient supplier. This relationship provides a distribution channel for raw material products in the nutraceutical supply chain.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large US-based manufacturer and distributor of natural and organic supplements, personal care, and sports nutrition. Broad incumbent operating across the same category but with broader product portfolio, in-house brands, and global distribution versus IBP's contract manufacturing focus.

TypeBroad incumbent
Description

Global nutrition company distributing meal replacement, weight-management, and supplement products through a multilevel marketing channel. Comparable as a counterpart in the nutraceutical MLM channel that buys contract-manufactured product similar to IBP's distributor and MLM customers.

TypeOthers
Description

Public functional beverage company with significant board overlap (Director Damon DeSantis and Chairman Emeritus William H. Milmoe sit on Celsius's board). Related through governance and nutraceutical-industry positioning rather than direct product competition.

TypeDirect peer
Description

Contract manufacturer and packager of vitamins, supplements, and OTC products in multiple dosage forms. Direct competitor to Manhattan Drug Company offering private-label and custom manufacturing services to similar distributor and multilevel marketer customers.

TypeDirect peer
Description

Contract manufacturer of nutritional supplements and OTC drug products based in California. Closely comparable as a similarly-sized private-label and custom-formulation supplement manufacturer serving MLM and distribution customers.

TypeDirect peer
Description

Contract manufacturer of dietary supplements, sports nutrition, and functional beverages. Closely comparable as a custom contract manufacturer serving brand owners in the nutraceutical channel, mirroring Manhattan Drug Company's core contract manufacturing business.

TypeDirect peer
Description

Contract manufacturer of nutritional supplements with focus on vitamins, minerals, and proprietary branded formulations. Comparable as a public custom contract manufacturer serving nutritional brand customers with similar capabilities to Manhattan Drug Company.

TypeDirect peer
Description

US-based manufacturer of whole-food nutritional supplements serving healthcare practitioners. Comparable as a vertically integrated US nutritional supplement manufacturer with custom formulation capabilities, similar to Manhattan Drug Company's contract manufacturing and specialty supplement focus.

TypeRegional player
Description

US specialty retailer of vitamins, supplements, and nutritional products. Comparable as a downstream retail channel for nutritional supplement brands, representing the type of mass-market and specialty retailer customer served by IBP's AgroLabs distribution subsidiary.

TypeEmerging player
Description

Global ingredient supplier of standardized botanical extracts and nutritional raw materials. Comparable through Chem International's role as a raw material distributor for DSM, operating at a similar node in the nutraceutical ingredient supply chain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Integrated BioPharma

Nutraceutical Manufacturingir.ibiopharma.com

Integrated BioPharma is a US-based contract manufacturer and distributor of vitamins, nutritional supplements, and herbal products, serving nutraceutical distributors, multilevel marketers, and retailers through five operating subsidiaries from its Hillside, NJ headquarters.

What Integrated BioPharma does

Integrated BioPharma, Inc. is a publicly traded (OTCQX: INBP), Delaware-incorporated holding company that manufactures, distributes, and sells vitamins, nutritional supplements, and herbal products for the nutraceutical industry. The company operates through five wholly owned subsidiaries: Manhattan Drug Company (contract manufacturing for distributors, multilevel marketers, and healthcare providers), AgroLabs (distribution to mass market, grocery, drug, and vitamin retailers), Chem International (raw materials distribution for DSM Nutritional Products), IHT Health Products (natural botanicals distribution under license), and MDC Warehousing and Distribution (warehousing and fulfillment services). Its core technology is US-based contract manufacturing of nutritional supplements with flexible customization capabilities, and its business model is B2B contract manufacturing and distribution with no disclosed direct-to-consumer or branded retail of its own.

The company is led by co-CEOs Christina Kay and Riva Kay Sheppard, who have served since the early 1990s, alongside CFO Dina L. Masi. Headquartered in Hillside, New Jersey with manufacturing operations in New Jersey and a sales office in Florida, the company operates exclusively within the United States. Its customer base consists of distributors, multilevel marketers, specialized healthcare providers, and mass market retailers, with revenue heavily concentrated in two large contract manufacturing customers that have represented approximately 83-90% of total revenue in recent periods. The company has 11-50 employees and a small market capitalization consistent with its micro-cap OTCQX listing.

Financially, the company is in a clear revenue contraction phase: nine-month revenue ended March 31, 2026 was $34.1M, down 15.2% year-over-year, with quarterly declines of 27.3% in Q1 FY2026 and 10.3% in Q2 FY2026. The company has shifted from operating profitability to an operating loss of $1.1M in Q1 FY2026 and a net loss of $0.8M, indicating margin pressure alongside the volume decline. No AI capabilities, recent acquisitions, or product launches are evident in the available data, and the company's strategic posture is defensive as it manages customer concentration risk and top-line erosion.

Integrated BioPharma firmographics

Firmographics
Name
Integrated BioPharma
Legal name
Integrated BioPharma, Inc.
Website
https://ir.ibiopharma.com
Company type
Public
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
Integrated BioPharma is a US-based contract manufacturer and distributor of vitamins, nutritional supplements, and herbal products, serving nutraceutical distributors, multilevel marketers, and retailers through five operating subsidiaries from its Hillside, NJ headquarters.
Ownership category
akta.pro rank

Integrated BioPharma industry classification

Industry
Product category
Nutraceutical Manufacturing
NAICS
Medicinal and Botanical Manufacturing (325411), Chemical and Allied Products Merchant Wholesalers (4246)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYAFAIAKAJ
Food-Grade Chemicals & Processing Aids Trading/Wholesale
Agriculture & Food Production/Food Distribution & Wholesale/Food Ingredients & Commodities Trading/Wholesale

Keywords

  • Contract manufacturing
  • Nutritional supplements
  • Vitamins distribution
  • Herbal products
  • Nutraceutical industry

Where Integrated BioPharma is headquartered

Location

Headquarters

HQ city
Hillside
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Integrated BioPharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Contract Manufacturing: The company manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers through its subsidiary Manhattan Drug Company, Inc. This is the primary revenue driver.
  2. Product Distribution: Distribution of nutritional products through major mass market, grocery, drug, and vitamin retailers via subsidiaries including AgroLabs, Chem International, and IHT Health Products.
  3. Raw Materials Distribution: Distribution of certain raw materials for DSM Nutritional Products LLC through Chem International, Inc.
  4. Warehousing and Fulfillment Services: Warehousing and fulfillment services provided through MDC Warehousing and Distribution, Inc.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels1 record

Integrated BioPharma product offering

Product offering

Core offering

Integrated BioPharma manufactures vitamins, nutritional supplements, and herbal products primarily through contract manufacturing relationships, and distributes nutritional products and raw materials through its subsidiaries. It serves the nutraceutical industry by providing US-manufactured, customizable products to distributors, multilevel marketers, healthcare providers, and mass-market retailers, complemented by warehousing and fulfillment services.

Product overview

Integrated BioPharma is a manufacturing and sales company engaged primarily in the manufacturing, distributing, marketing, and sales of vitamins, nutritional supplements, and herbal products. The company operates through five distinct subsidiaries: Manhattan Drug Company (contract manufacturing of vitamins and nutritional supplements), AgroLabs (distribution to mass market, grocery, and drug retailers), Chem International (raw materials distribution), IHT Health Products (natural botanicals distribution), and MDC Warehousing and Distribution (warehousing and fulfillment services). The portfolio is structured as a platform of operating companies serving the nutraceutical industry.

Differentiator

Problem solved

Functional benefit

Brands

  • Manhattan Drug Company: Contract manufacturer of vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers.
  • AgroLabs
  • IHT Health Products
  • MDC Warehousing and Distribution

Products and services

  • Contract Manufacturing of Vitamins and Nutritional Supplements Contract manufacturing of vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers, operated through subsidiary Manhattan Drug Company, Inc.
  • Nutritional Product Distribution Distribution of healthful nutritional products for sale through major mass market, grocery, drug, and vitamin retailers, with customization for resale or direct-to-consumer, operated through subsidiary AgroLabs, Inc.
  • Raw Materials Distribution

Companies that use Integrated BioPharma

Customer profile

Segments4 records

Ideal customer profiles4 records

Integrated BioPharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integrated BioPharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DSM Nutritional Products LLCminorOthersChem International, Inc. serves as a distributor of certain raw materials for DSM Nutritional Products LLC, a major nutritional ingredient supplier. This relationship provides a distribution channel for raw material products in the nutraceutical supply chain.

Scale indicators9 records

Recent moves7 records

Expansion highlights2 records

Integrated BioPharma competitors and assessment

Company assessment

Broad incumbents

  • NOW Foods: Large US-based manufacturer and distributor of natural and organic supplements, personal care, and sports nutrition. Broad incumbent operating across the same category but with broader product portfolio, in-house brands, and global distribution versus IBP's contract manufacturing focus.
  • Herbalife: Global nutrition company distributing meal replacement, weight-management, and supplement products through a multilevel marketing channel. Comparable as a counterpart in the nutraceutical MLM channel that buys contract-manufactured product similar to IBP's distributor and MLM customers.

Others

  • Celsius Holdings: Public functional beverage company with significant board overlap (Director Damon DeSantis and Chairman Emeritus William H. Milmoe sit on Celsius's board). Related through governance and nutraceutical-industry positioning rather than direct product competition.

Direct peers

  • Makers Nutrition: Contract manufacturer and packager of vitamins, supplements, and OTC products in multiple dosage forms. Direct competitor to Manhattan Drug Company offering private-label and custom manufacturing services to similar distributor and multilevel marketer customers.
  • Robinson Pharma: Contract manufacturer of nutritional supplements and OTC drug products based in California. Closely comparable as a similarly-sized private-label and custom-formulation supplement manufacturer serving MLM and distribution customers.
  • NutraScience Labs: Contract manufacturer of dietary supplements, sports nutrition, and functional beverages. Closely comparable as a custom contract manufacturer serving brand owners in the nutraceutical channel, mirroring Manhattan Drug Company's core contract manufacturing business.
  • Natural Alternatives International: Contract manufacturer of nutritional supplements with focus on vitamins, minerals, and proprietary branded formulations. Comparable as a public custom contract manufacturer serving nutritional brand customers with similar capabilities to Manhattan Drug Company.
  • Standard Process: US-based manufacturer of whole-food nutritional supplements serving healthcare practitioners. Comparable as a vertically integrated US nutritional supplement manufacturer with custom formulation capabilities, similar to Manhattan Drug Company's contract manufacturing and specialty supplement focus.

Regional players

  • Vitamin Shoppe (parent: Franchise Group): US specialty retailer of vitamins, supplements, and nutritional products. Comparable as a downstream retail channel for nutritional supplement brands, representing the type of mass-market and specialty retailer customer served by IBP's AgroLabs distribution subsidiary.

Emerging players

  • BGG Americas: Global ingredient supplier of standardized botanical extracts and nutritional raw materials. Comparable through Chem International's role as a raw material distributor for DSM, operating at a similar node in the nutraceutical ingredient supply chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Customer concentration

Integrated BioPharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Integrated BioPharma leadership team

Management profile

Number of profiles

Profiles7 records

Integrated BioPharma subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Integrated BioPharma funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Integrated BioPharma M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Integrated BioPharma

What does Integrated BioPharma do?

Integrated BioPharma manufactures vitamins, nutritional supplements, and herbal products primarily through contract manufacturing relationships, and distributes nutritional products and raw materials through its subsidiaries. It serves the nutraceutical industry by providing US-manufactured, customizable products to distributors, multilevel marketers, healthcare providers, and mass-market retailers, complemented by warehousing and fulfillment services.

Is Integrated BioPharma a public or private company?

Integrated BioPharma is a public company. It is classified as public and is currently operating.

When was Integrated BioPharma founded?

Integrated BioPharma was founded in 1995. It employs 11 to 50 people.

Where is Integrated BioPharma based?

Integrated BioPharma is headquartered in Hillside, United States, in the North America region.

How does Integrated BioPharma make money?

Four revenue lines are on record. Contract Manufacturing is the primary driver. The others are product Distribution, raw Materials Distribution and warehousing and Fulfillment Services.

Who are Integrated BioPharma's main competitors?

Broad incumbents on record are NOW Foods and Herbalife. Celsius Holdings is listed as an others. Direct peers are Makers Nutrition, Robinson Pharma, NutraScience Labs, Natural Alternatives International and Standard Process. Vitamin Shoppe (parent: Franchise Group) is listed as a regional player. BGG Americas is listed as an emerging player.

Does Integrated BioPharma have an API?

No public API is recorded for Integrated BioPharma.

What industry is Integrated BioPharma in?

Integrated BioPharma's product category is Nutraceutical Manufacturing. Its primary akta.pro industry code is CRADAOAO, Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends), with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Quiver QuantitativeIntegrated BioPharma Reports $1.4 Million Quarterly Net Loss | INBP Stock NewsIntegrated BioPharma reported quarterly revenue of $9.8 million, down 31% year-over-year, and a net loss of $1.4 million for the quarter ended June 30, 2026. Fiscal-year revenue fell 19.3% to $43.9 million, with a net loss of $2.8 million. The company's two largest contract manufacturing customers accounted for about 90% of fiscal 2026 revenue.FinancialContent Business PageIntegrated Biopharma's Wholly-Owned Subsidiary, Manhattan Drug Company, Inc. Appoints Michael Richtmyer as Head of OperationsIntegrated BioPharma, Inc. announced that its wholly-owned subsidiary, Manhattan Drug Company (MDC), appointed Michael Richtmyer as Head of Operations on August 3, 2026. Richtmyer brings over 35 years of experience in manufacturing and supply chain management to lead operational strategies and execution across MDC. This appointment aims to enhance manufacturing performance, quality systems, and scalable growth for the contract manufacturer.Stock TitanIntegrated BioPharma Appoints Manhattan Drug Operations HeadIntegrated BioPharma's subsidiary, Manhattan Drug Company, appointed Michael Richtmyer as Head of Operations on August 3, 2026. Richtmyer brings over 35 years of experience in manufacturing and supply chain management to lead operational strategies across the company. He previously worked with Integrated BioPharma from 1991 to 1999 before taking a senior role at Tishcon Corp.BioSpaceIntegrated BioPharma Reports Results for its Quarter Ended March 31, 2026Integrated BioPharma reported Q1 2026 revenue of $10.1 million, down 27.3% year-over-year, and an operating loss of $1.1 million. Nine-month revenue fell 15.2% to $34.1 million, with net loss of $0.8 million for the quarter and $1.5 million for nine months.Stock TitanIntegrated BioPharma revenue falls 27% to $10.1MIntegrated BioPharma reported a 27.3% decline in quarterly revenue to $10.1 million for Q1 2026, down from $13.9 million in the same quarter of 2025, alongside an operating loss of $1.1 million compared to operating income of $0.7 million the prior year. The company also reported a net loss of $0.8 million for the quarter versus net income of $0.6 million year-over-year, with per-share loss of $(0.03) versus earnings of $0.02. For the nine-month period ended March 31, 2026, revenue fell 15.2% to $34.1 million, with the company noting that its two largest customers in the Contract Manufacturing Segment represented approximately 90% and 83% of total revenue in the respective periods.Stock TitanIntegrated BioPharma revenue down 10.3%, $0.8M lossIntegrated BioPharma, Inc. reported financial results for the quarter ended December 31, 2025, with revenue declining 10.3% year-over-year to $11.3 million from $12.6 million, alongside an operating loss of $0.9 million compared to operating income of $0.2 million in the prior-year quarter. The company posted a net loss of $0.8 million for the quarter versus net income of approximately $0.1 million a year earlier. For the six-month period, revenue fell 8.4% to $24.0 million, and the company noted that approximately 89% of revenue was concentrated in its two largest customers in the Contract Manufacturing Segment.Stock TitanINBP Stock Price, News & AnalysisIntegrated BioPharma Inc. (INBP), a manufacturer in the pharmaceutical preparation industry, focuses primarily on vitamins, nutritional supplements, and herbal products, with its core operations centered on contract manufacturing. The company's revenue heavily depends on two major customers in its Contract Manufacturing Segment, which it aims to diversify. It is a publicly traded company on the OTCQX market and follows standard U.S. governance and disclosure practices.YahooIntegrated BioPharma Reports Results for Its Quarter Ended September 30, 2025Integrated BioPharma, Inc. reported its financial results for the quarter ending September 30, 2025, showing a decrease in revenue and net income compared to the previous year. The company's revenue was $12.7 million, down approximately 6.6%, and net income was $0.1 million. The results highlight challenges faced by the company in its manufacturing and sales operations.YahooIntegrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025Integrated BioPharma, Inc. reported its financial results for the quarter and fiscal year ending June 30, 2025, showing revenue increases of 11.8% and 8.0%, respectively. The company experienced a net loss in the quarter but had a net income for the year, with a focus on expanding its customer base and revenue despite some losses.PR NewswireOTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQXOTC Markets Group Inc. announced on January 22, 2021 that Integrated BioPharma, Inc. has qualified to trade on the OTCQX Best Market after upgrading from the OTCQB Venture Market, with trading beginning under the symbol "INBP". To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. The Executive Chairman stated that the upgrade represents an achievement as the company continues to grow and increase shareholder value.